NEW YORK, February 7, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that Debbie Warner, Vice President, Commercial Planning, will be presenting at eyeforpharma’s Oncology Market Access USA Summit 2012. The meeting will be held February 14-15 at the Boston Park Plaza Hotel.
Ms. Warner will present “Evolution of Medicare and Its Impact on Oncology Product Coverage and Reimbursement” on February 14. The presentation will help attendees:
- Gain insight into how Medicare’s reimbursement policy will evolve
- Understand the impact of coverage, provider reimbursement, patient affordability and delivery system availability
- Understand how to adapt your marketing strategy to tougher market conditions and learn how to work toward sustaining current levels of access
Ms. Warner leads Kantar Health’s Oncology Commercial Strategies team, which recently released the Consumerism in Oncology module, a proprietary analysis that focuses on the growing importance of patients in healthcare decision-making in cancer. In this analysis, Kantar Health describes the emergence of the patient as a key stakeholder in decisions about cancer therapies and implications of this evolving trend.
Consumerism in Oncology reviews the different types of cost shifting and their impact on patient behavior. Included are results of Kantar Health’s patient study, which was designed as a trade-off analysis to determine the importance of product characteristics, including cost to the patient, in the decision to ask about or undergo cancer treatment. The analysis provides insight into the changing role of the patient and challenges around communicating value to this increasingly important stakeholder.
Kantar Health is a global sponsor of the Oncology Market Access USA 2012 conference.
About Oncology Market Access US
Kantar Health’s Oncology Market Access US provides cutting-edge analyses of how economic considerations and politics are shaping the US oncology landscape. These web-resident analyses are based on industry experience and in-depth research with key stakeholders, including oncologists, payers, practice managers, patients, economists, policy thought leaders, and other subject matter experts.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.